[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ArmandOrlandi Armando OrlandiArmando Orlandi posts on X about status, broccoli, ai, future the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Social topic influence status, broccoli, ai, future, science, os, mets
Top posts by engagements in the last XX hours
"Cruciferous Vegetables π₯¦ Do cruciferous vegetables protect against BC π NHS + NHSII: 169523 women 4.5M person-years X serving/day vs 1/week: Overall BC: HR XXXX ER-negative: HR XXXX (p-trend=0.01) π¬ Glucosinolates isothiocyanates protective effect π‘ Stronger effect in women with BMI25 for ER- tumors Broccoli cauliflower cabbage eat up π₯¬ @OncoAlert @SABCSSanAntonio"
X Link 2025-12-09T23:24Z XXX followers, 2183 engagements
"APHINITY TILs Analysis (GS1-05) π€ Human vs Machine: Who scores TILs better APHINITY mega-analysis (n=4306): Plot twist BOTH win Manual Digital AI all predict outcomes β
But heres where AI shines: Identifies XX% MORE pts who benefit from pertuzumab Spatial immune hotspots = strongest prognostic signal (HR 0.41) High TILs + Pertuzumab = XX% event reduction The future of pathology is hybrid π¬π€ @oncodaily @SABCSSanAntonio"
X Link 2025-12-10T16:47Z XXX followers, XXX engagements
"PHERGain ctDNA (GS1-06) 𧬠Can a blood test predict chemo-free success in HER2+ BC PHERGain says YES. The smoking gun π« NO patient with detectable ctDNA at surgery achieved pCR. Zero. Nada. ctDNA clearance after just X cycles Strongly predicts pCR (p=0.003) Baseline ctDNA+ 3y iDFS XXXX% Baseline ctDNA- 3y iDFS XXX% Liquid biopsy meets de-escalation. Beautiful science. π― @OncoAlert @SABCSSanAntonio"
X Link 2025-12-10T16:59Z XXX followers, XXX engagements
"Cowabunga Riding Breast Cancer's Biggest Datas Wave ππ»βππ€π»from #SABCS25 Thread: Catch the Wave πβ Rapid Fire X @OncoAlert @SABCSSanAntonio"
X Link 2025-12-11T22:33Z XXX followers, XXX engagements
"Cowabunga Riding Breast Cancer's Biggest Datas Wave ππ»βππ€π»from #SABCS25 Thread: Catch the Wave πβGeneral Session X @OncoAlert @SABCSSanAntonio"
X Link 2025-12-10T15:43Z XXX followers, XXX engagements
"Cowabunga Riding Breast Cancer's Biggest Datas Wave ππ»βππ€π»from #SABCS25 Thread: Catch the Wave πβ Rapid Fire X @OncoAlert @SABCSSanAntonio"
X Link 2025-12-10T22:30Z XXX followers, XXX engagements
"PALLAS ctDNA Analysis (RF3-04) 𧬠PALLAS ctDNA: The MRD question in HR+/HER2- BC π 1280 patients selected Tumor-informed Signatera assay Samples at C1D1 C6D1 end of treatment 7-year median follow-up cDNA status at C1D1 C6D1 and EOT is highly prognostic in HR+/HER2- eBC @OncoAlert @SABCSSanAntonio"
X Link 2025-12-10T23:06Z XXX followers, XXX engagements
"Alliance A011104 MRI (GS2-07) π§² Does preop MRI improve outcomes in early TNBC/HER2+ BC π Alliance A011104: XXX patients randomized to MRI vs no MRI 5-year local-regional control: MRI: XXXX% No MRI: XXXX% HR XXX (95% CI 0.3-3.9) NO DIFFERENCE in LRR distant recurrence or OS BCS rates identical: XX% in both arms π‘ In the era of effective systemic therapy MRI for surgical planning doesnt improve oncologic outcomes @OncoAlert @SABCSSanAntonio"
X Link 2025-12-11T16:45Z XXX followers, XXX engagements
"Clarity BCR Algorithm (RF3-07) π§ Clarity BCR: Deep learning predicts LATE recurrence Validated in TAILORx (n=6516) after B-42 development Late DR (5 years) performance: High vs Low risk: HR XXXX (p0.001) 15y DRFI: XXXX% vs XXXX% C-index: XXXX (vs XXXX for Oncotype) Independent of: β
Tumor size β
Grade β
Oncotype RS β
Menopausal status In B-42: Identified XX% who benefit from extended ET (4% absolute benefit) H&E + clinical data = personalized EET decisions π― @OncoAlert @SABCSSanAntonio"
X Link 2025-12-10T23:29Z XXX followers, XXX engagements
"Cowabunga Riding Breast Cancer's Biggest Datas Wave ππ»βππ€π»from #SABCS25 Thread: Catch the Wave πβ General Session X @OncoAlert @SABCSSanAntonio"
X Link 2025-12-11T14:51Z XXX followers, XXX engagements
"PATINA CNS Outcomes (RF4-01) π§ PATINA: Palbociclib protects the brain HER2+/HR+ MBC maintenance: Palbociclib + anti-HER2 + ET CNS progression at XX months (no baseline CNS mets): Palbociclib: XXXX% Control: XXXX% Grays test p=0.0378 β
Absolute reduction: XXX% at X years Benefit seen early (12 mo) and sustained over time. π‘ Palbociclib may help delay/prevent CNS involvement in HR+/HER2+ MBC @OncoAlert @SABCSSanAntonio"
X Link 2025-12-11T22:36Z XXX followers, XXX engagements